iTeos Therapeutics, Inc.

The momentum for this stock is not very good. iTeos Therapeutics, Inc. has good growth characteristics. iTeos Therapeutics, Inc. is not very popular among insiders. iTeos Therapeutics, Inc. is a mediocre stock to choose.
Log in to see more information.

News

509,303 Shares in iTeos Therapeutics, Inc. (NASDAQ:ITOS) Bought by Candriam S.C.A.
509,303 Shares in iTeos Therapeutics, Inc. (NASDAQ:ITOS) Bought by Candriam S.C.A.

Ticker Report Candriam S.C.A. purchased a new stake in shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS - Free Report) during the second quarter, HoldingsChannel reports. The fund purchased 509,303 shares of the...\n more…

Panagora Asset Management Inc. Purchases 10,787 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS)
Panagora Asset Management Inc. Purchases 10,787 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS)

Zolmax Panagora Asset Management Inc. boosted its holdings in iTeos Therapeutics, Inc. (NASDAQ:ITOS - Free Report) by 8.9% in the 2nd quarter, according to the company in its most recent filing with the...\n more…

iTeos to Participate in Upcoming Investor Conferences
iTeos to Participate in Upcoming Investor Conferences

Globe Newswire WATERTOWN, Mass. and GOSSELIES, Belgium, Aug. 28, 2024 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS) ( iTeos ), a clinical-stage biopharmaceutical company pioneering the discovery and...\n more…

iTeos Therapeutics Announces Late-Breaking Oral Presentation of Phase 2 GALAXIES Lung-201 Interim Data at the European Society for Medical Oncology Congress 2024
iTeos Therapeutics Announces Late-Breaking Oral Presentation of Phase 2 GALAXIES Lung-201 Interim Data at the European Society for Medical Oncology Congress 2024

Globe Newswire WATERTOWN, Mass. and GOSSELIES, Belgium, Aug. 20, 2024 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS) ( iTeos ), a clinical-stage biopharmaceutical company pioneering the discovery and...\n more…

California State Teachers Retirement System Trims Stake in iTeos Therapeutics, Inc. (NASDAQ:ITOS)
California State Teachers Retirement System Trims Stake in iTeos Therapeutics, Inc. (NASDAQ:ITOS)

Ticker Report California State Teachers Retirement System lessened its holdings in iTeos Therapeutics, Inc. (NASDAQ:ITOS - Free Report) by 5.6% during the first quarter, according to its most recent disclosure...\n more…

Reviewing Sorrento Therapeutics (OTCMKTS:SRNEQ) and iTeos Therapeutics (NASDAQ:ITOS)
Reviewing Sorrento Therapeutics (OTCMKTS:SRNEQ) and iTeos Therapeutics (NASDAQ:ITOS)

Zolmax iTeos Therapeutics (NASDAQ:ITOS - Get Free Report) and Sorrento Therapeutics (OTCMKTS:SRNEQ - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the...\n more…